Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Greenwich LifeSciences (GLSI)
NASDAQ:GLSI
RESEARCH TOOLSreports
Greenwich LifeSciences (GLSI) Stock Price & Analysis
354 Followers
GLSI Stock Chart & Stats
Day’s Range$13.93 - $14.62
52-Week Range― - ―
Previous Close$13.99
Volume35.83K
Average Volume (3M)N/A
Market Cap
$185.32M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$36.00Price Target Upside150.17% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Greenwich LifeSciences News
Ownership Overview
94.86% Insiders
2.10% Mutual Funds
1.80% Other Institutional Investors
1.23% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
GLSI FAQ
What was Greenwich LifeSciences’s price range in the past 12 months?
Currently, no data Available
What is Greenwich LifeSciences’s market cap?
Currently, no data Available
When is Greenwich LifeSciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Greenwich LifeSciences’s earnings last quarter?
Currently, no data Available
Is Greenwich LifeSciences overvalued?
According to Wall Street analysts Greenwich LifeSciences’s price is currently Undervalued.
Does Greenwich LifeSciences pay dividends?
Greenwich LifeSciences does not currently pay dividends.
What is Greenwich LifeSciences’s EPS estimate?
Greenwich LifeSciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Greenwich LifeSciences have?
Currently, no data Available
What happened to Greenwich LifeSciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Greenwich LifeSciences?
Currently, no hedge funds are holding shares in GLSI
---
Greenwich LifeSciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$36.00 (150.17% Upside)
$36.00 (150.17% Upside)
Insider Transactions
Bought Shares
Worth $829.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 0.5%
Last 30 Days ▼ 0.5%
Technicals
SMA
Positive
20 days / 200 days
Momentum
25.02%
12-Months-Change
Fundamentals
Return on Equity
-89.30%
Trailing 12-Months
Asset Growth
-48.10%
Trailing 12-Months
Company Description
Greenwich LifeSciences
Greenwich LifeSciences Inc is a clinical stage bio-pharmaceutical company focused on the development of an immunotherapy to prevent breast cancer recurrences in patients.
---
GLSI Stock 12 Months Forecast
Average Price Target
$36.00
▲(150.17% Upside)
Technical Analysis
Best Analysts Covering GLSI
1 Year
1 Year Success Rate
4/9 ratings generated profit
1 Year Average Return
-13.23%
reiterated a buy rating 2 months ago
Copying Yi Chen's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of -13.23% per trade.
---